当前位置:首页 - 行情中心 - 之江生物(688317) - 财务分析 - 现金流量表

之江生物

(688317)

  

流通市值:40.93亿  总市值:40.93亿
流通股本:1.92亿   总股本:1.92亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金120,213,144.2280,671,108.6341,890,096.09214,886,011.55
  收到的税费返还---3,401,204.06
  收到其他与经营活动有关的现金51,878,128.1343,534,92011,782,623.92120,594,185.46
  经营活动现金流入小计172,091,272.35124,206,028.6353,672,720.01338,881,401.07
  购买商品、接受劳务支付的现金17,018,580.4810,449,478.028,925,158.9344,728,265.83
  支付给职工以及为职工支付的现金57,114,359.5140,242,703.6122,102,122.2297,574,616.22
  支付的各项税费13,908,036.039,796,6485,473,910.4720,612,608.39
  支付其他与经营活动有关的现金51,377,879.6637,892,891.415,170,486.2198,377,198.59
  经营活动现金流出小计139,418,855.6898,381,721.0351,671,677.83261,292,689.03
  经营活动产生的现金流量净额32,672,416.6725,824,307.62,001,042.1877,588,712.04
二、投资活动产生的现金流量:
  收回投资收到的现金694,998,538.3284,689,173.1546,676,231.4521,592,932.28
  处置固定资产、无形资产和其他长期资产收回的现金净额340,0000-12,000
  投资活动现金流入小计695,338,538.3284,689,173.1546,676,231.4521,604,932.28
  购建固定资产、无形资产和其他长期资产支付的现金3,068,392.52,974,379.52,399,849.519,485,362.23
  投资支付的现金1,011,507,951.71597,598,133.5195,399,008.521,535,811.82
  投资活动现金流出小计1,014,576,344.21600,572,513197,798,85841,021,174.05
  投资活动产生的现金流量净额-319,237,805.91-315,883,339.85-151,122,626.55-19,416,241.77
三、筹资活动产生的现金流量:
  取得借款收到的现金198,000,000198,000,00099,000,000-
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计198,000,000198,000,00099,000,000-
  偿还债务支付的现金1,980,000---
  分配股利、利润或偿付利息支付的现金1,840,803.25875,737.5203,50020,882,808.32
  支付其他与筹资活动有关的现金221,026,950.57182,926,350.1889,214,667.8737,837,578.55
  筹资活动现金流出小计224,847,753.82183,802,087.6889,418,167.8758,720,386.87
  筹资活动产生的现金流量净额-26,847,753.8214,197,912.329,581,832.13-58,720,386.87
四、汇率变动对现金及现金等价物的影响-9,676,055.88-2,373,500.83-1,067,681.9514,442,150.56
五、现金及现金等价物净增加额-323,089,198.94-278,234,620.76-140,607,434.1913,894,233.96
  加:期初现金及现金等价物余额2,783,392,638.522,783,176,213.262,783,392,638.522,769,281,979.3
  期末现金及现金等价物余额2,460,303,439.582,504,941,592.52,642,785,204.332,783,176,213.26
补充资料:
  净利润--9,850,972.77--127,462,123.71
  资产减值准备--9,593,246.29-162,849,610.59
  固定资产和投资性房地产折旧-25,541,006.04-65,385,568.02
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-25,541,006.04-65,385,568.02
  无形资产摊销-554,391.84-994,936.7
  长期待摊费用摊销-353,985.22-723,423
  处置固定资产、无形资产和其他长期资产的损失-333,569.04--39,305.59
  固定资产报废损失---5,982,257.69
  财务费用-4,142,590.48--14,038,898.59
  投资损失--1,069,991.04--57,120.46
  递延所得税--2,213,818.1--23,249,337.21
  其中:递延所得税资产减少--2,213,818.1--22,795,309.22
    递延所得税负债增加-0--454,027.99
  存货的减少-13,423,914.91-36,368,902.3
  经营性应收项目的减少-19,042,589.92-37,313,578.51
  经营性应付项目的增加--15,779,950.85--81,053,201.04
  其他---975,359.3
  不涉及现金收支的投资和筹资活动金额其他项目---424,087.67
  现金的期末余额-2,504,941,592.5-2,783,176,213.26
  减:现金的期初余额-2,783,176,213.26-2,769,281,979.3
  现金及现金等价物的净增加额--278,234,620.76-13,894,233.96
公告日期2025-10-302025-08-292025-04-302025-04-25
审计意见(境内)标准无保留意见
TOP↑